{"prompt": "['MC1575', '34', 'Amendment 2', 'NOTE: *The consent form may contain study specific information at the discretion of the', 'Principal Investigator; it is possible that this information may NOT be included in the', 'protocol or the investigator brochure. Refer to protocol or IB for reporting needs.', '10.3', 'Attribution to agent(s) or procedure', 'When assessing whether an adverse event (AE) is related to a medical agent(s) medical or', 'procedure, the following attribution categories are utilized:', 'Definite - The AE is clearly related to the agent(s)/procedure.', 'Probable - The AE is likely related to the agent(s)/procedure.', 'Possible - The AE may be related to the agent(s)/procedure.', 'Unlikely - The AE is doubtfully related to the agent(s)/procedure.', 'Unrelated - The AE is clearly NOT related to the agent(s)/procedure.', '10.31', 'EXPECTED Serious Adverse Events: Protocol Specific Exceptions to', 'Expedited Reporting', 'For this protocol only, the following Adverse Events/Grades are expected to occur', 'within this population and do not require Expedited Reporting. These events must still', 'be reported via Routine Reporting (see Section 10.6).', '*Report any clinically important increase in the rate of a serious suspected', 'adverse reaction (at your study site) over that which is listed in the protocol or', 'investigator brochure as an expedited event.', '*Report an expected event that is greater in severity or specificity than expected', 'as an expedited event.', 'CTCAE Grade at which the event', 'System Organ Class', 'will not be reported in an expedited', '(SOC)', 'Adverse event/ Symptoms', 'manner\u00b9', 'Blood and lymphatic', 'Anemia', 'Grade 4', 'system disorders', 'Investigations', 'Lymphocyte count decreased', 'Grade 4', 'Neutrophil count decreased', 'Grade 4', 'Platelet count decreased', 'Grade 4', 'White blood cell count', 'Grade 4', 'decreased', 'General disorders and', 'Fatigue', 'Grade 3', 'administrations site', 'Malaise', '<Grade 3', 'conditions', 'Nausea', 'Grade 3', 'Gastrointestinal disorders', 'Vomiting', '<Grade 3', 'Diarrhea', '<Grade 3', 'Renal and urinary', 'Proteinuria', '<Grade 2', 'disorders', 'Skin and subcutaneous', 'Alopecia', 'Grade 2', 'tissue disorders', 'Rash', '<Grade 3', 'Vascular disorders', 'Hypertension', '<Grade 3', 'These exceptions only apply if the adverse event does not result in hospitalization. If the adverse', 'event results in hospitalization, then the standard expedited adverse events reporting', 'requirements must be followed.', 'Specific protocol exceptions to expedited reporting should be reported expeditiously', 'by', 'investigators ONLY if they exceed the expected grade of the event.', 'Protocol Version Date:16Aug2018']['MC1575', '35', 'Amendment 2', 'The following hospitalizations are not considered to be SAEs because there is no \"adverse event\"', '(i.e., there is no untoward medical occurrence) associated with the hospitalization:', 'Hospitalizations for respite care', 'Planned hospitalizations required by the protocol', 'Hospitalization planned before informed consent (where the condition requiring the', 'hospitalization has not changed post study drug administration)', 'Hospitalization for elective procedures unrelated to the current disease and/or treatment on this', 'trial', 'Hospitalization for administration of study drug or insertion of access for administration of', 'study drug', 'Hospitalization for routine maintenance of a device (e.g., battery replacement) that was in place', 'before study entry', 'Hospitalization, or other serious outcomes for signs and symptoms of progression of the cancer.', '10.4', 'Expedited Reporting Requirements for IND/IDE Agents', '10.41 Phase 1 and Early Phase 2 Studies: Expedited Reporting Requirements for', 'Adverse Events that Occur on Studies under an IND/IDE within 30 Days of', 'the Last Administration of the Investigational Agent/Intervention', '1,2', 'FDA REPORTING REQUIREMENTS FOR SERIOUS ADVERSE EVENTS (21 CFR Part 312)', 'NOTE: Investigators MUST immediately report to the sponsor ANY Serious Adverse Events, whether or not they', 'are considered related to the investigational agent(s)/intervention (21 CFR 312.64)', 'An adverse event is considered serious if it results in ANY of the following outcomes:', '1) Death', '2)', 'A life-threatening adverse event', '3)', 'An adverse event that results in inpatient hospitalization or prolongation of existing hospitalization for 24', 'hours', '4)', 'A persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions', '5)', 'A congenital anomaly/birth defect.', '6)', 'Important Medical Events (IME) that may not result in death, be life threatening, or require hospitalization', 'may be considered serious when, based upon medical judgment, they may jeopardize the patient or subject', 'and may require medical or surgical intervention to prevent one of the outcomes listed in this definition. (FDA,', '21 CFR 312.32; ICH E2A and ICH E6).', 'ALL SERIOUS adverse events that meet the above criteria MUST be immediately reported to the sponsor within', 'the timeframes detailed in the table below.', 'Grade 3-5', 'Hospitalization', 'Grade 1 and Grade 2 Timeframes', 'Timeframes', 'Resulting in', 'Hospitalization', '7 Calendar Days', '>24 hrs', '24-Hour 3 Calendar', 'Not resulting in', 'Days', 'Hospitalization', 'Not required', '>24 hrs', 'Expedited AE reporting timelines are defined as:', '\"24-Hour; 3 Calendar Days\" - The AE must initially be reported within 24 hours of learning of the AE,', 'followed by a complete expedited report within 3 calendar days of the initial 24-hour report.', '\"7 Calendar Days\" - A complete expedited report on the AE must be submitted within 7 calendar days', 'of learning of the AE.', '1', 'Serious adverse events that occur more than 30 days after the last administration of investigational', 'agent/intervention and have an attribution of possible, probable, or definite require reporting as follows:', 'Expedited 24-hour notification followed by complete report within 3 calendar days for:', 'All Grade 3, 4, and Grade 5 AEs', 'Expedited 7 calendar day reports for:', 'Grade 2 AEs resulting in hospitalization or prolongation of hospitalization', 'Protocol Version Date:16Aug2018']\n\n###\n\n", "completion": "END"}